Chicago & Midwest CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Biopharma Firm Upsizes in Fulton Market Lease
Making room for planned new hires and a local workforce that has nearly doubled over the past two years, Xeris Biopharma Holdings has signed a 13-year lease for about 87,000 square feet at Trammell Crow Company’s 1375 W. Fulton St. In the Fulton Market District, reported Crain’s Chicago Business. The injectable-drug maker had moved its research team from California to Chicago in 2020, early in the COVID-19 pandemic
The new space marks an expansion from Xeris’ existing real estate footprint in the city, which includes a 40,000-square-foot headquarters at 180 N. LaSalle St. and an 11,000-square-foot research lab at 1375 W. Fulton. It also represents a big boost to Fulton Market’s emerging reputation as a biotech hub, Crain’s reported.
CBRE vice chairman Kyle Kamin negotiated the new lease on behalf of Xeris. CBRE SVP Kelsey Scheive represented TCC in negotiations.
- ◦Lease
